Pembrolizumab for Patients With Non-Hodgkin Lymphoma Who Were Ineligible for or Failed Auto-HCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
Leukemia and Lymphoma 2022 Nov 18;[EPub Ahead of Print], J Kuruvilla, P Armand, M Hamadani, J Kline, CH Moskowitz, D Avigan, JD Brody, V Ribrag, AF Herrera, F Morschhauser, A Kanate, PL Zinzani, J Bitran, H Ghesquieres, SJ Schuster, M Farooqui, P Marinello, NL BartlettFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.